Acute and chronic bacterial prostatitis

01OverviewDefinition, clinical context and the essential points that orientate the chapter.

Prostatitis describes more than one syndrome. Acute bacterial prostatitis is an infection that may produce substantial systemic illness and urinary obstruction. Chronic bacterial prostatitis can present with recurring infections caused by the same organism, pelvic discomfort and intervals of partial improvement. Chronic pelvic pain syndrome can produce similar pain and urinary symptoms without demonstrated bacterial infection, and repeated antibiotic exposure does not become justified simply because symptoms are longstanding.

An effective prescription must reach prostate tissue and address the organism for an appropriate duration. Nitrofurantoin may suppress accompanying bladder symptoms while leaving a prostate reservoir untreated. Conversely, prolonged ciprofloxacin for nonspecific pelvic pain creates avoidable risk. History, properly interpreted cultures and specialist localisation testing in selected stable patients help distinguish these situations. Acute systemic management should never wait for chronic diagnostic tests.

Key points

Acute fever, perineal pain, dysuria and obstructive symptoms suggest bacterial prostatitis; retention, sepsis or suspected abscess requires hospital assessment. If ceftriaxone is chosen, hypersensitivity to any cephalosporin or a severe reaction to another beta lactam excludes that medicine.
Collect midstream urine for culture and examine gently when indicated; never perform vigorous prostate massage during suspected acute bacterial infection.
For acute prostatitis, review antibiotics after fourteen days and decide whether to stop or continue for another fourteen using symptoms, examination and investigations.
Chronic bacterial prostatitis usually involves symptoms for at least three months with evidence of a bacterial reservoir; chronic pelvic pain alone does not establish infection.
A culture-directed chronic bacterial course commonly lasts four to six weeks; a fluoroquinolone requires documented reasons other recommended antibiotics are inappropriate.
Stop a fluoroquinolone and seek prompt assessment for tendon pain, neuropathy or serious neurological or psychiatric symptoms; avoid combining it with systemic corticosteroids.

02AetiologyUnderlying causes, associations and risk factors, with why each one matters.

Bacterial entry

Organisms can enter prostate ducts from infected urine or following urinary instrumentation. Enteric Gram-negative bacteria are common, while the clinical setting helps determine whether other pathogens need consideration.

Persistent prostate infection

A bacterial reservoir within prostate tissue can cause repeated urinary episodes over months. A pattern of culture-documented recurrence supports further assessment rather than assuming unrelated bladder infections.

03PathophysiologyThe causal sequence from the underlying abnormality to symptoms and harm.

1
Acute inflammation
Inflammatory swelling and tissue sensitivity produce pelvic pain, urinary symptoms and sometimes fever. Swelling around the urethral channel can worsen voiding and contribute to acute retention.
2
Tissue exposure
Successful treatment of a prostate infection requires adequate antimicrobial exposure within prostate tissue. Urinary concentration alone is insufficient when bacteria persist outside the bladder lumen.
3
Bacteraemic spread
Manipulation of an acutely infected prostate may promote bacterial entry into the circulation. Systemic spread can cause sepsis, making aggressive massage an unsafe diagnostic manoeuvre in acute disease.

04Clinical features and red flagsSymptoms, examination findings, patterns of presentation and time-critical warnings.

Acute prostate syndrome

Ask about sudden pelvic or perineal pain, painful ejaculation, dysuria, poor stream, fever and rigors. A tender swollen prostate on a gentle examination supports the diagnosis but is not required before acting on severe illness.

Admission triggersRed flag

Sepsis, inability to pass urine, severe dehydration, suspected prostate abscess or failure to improve within forty eight hours of treatment warrants hospital assessment. Do not attempt repeated traumatic catheterisation in a distressed patient.

Chronic bacterial pattern

Symptoms lasting at least three months with recurrent culture-documented infections suggest a possible prostate reservoir. Record symptom-free intervals, organism identities and previous drugs rather than assuming every recurrent dysuria episode has the same cause.

Pain without demonstrated bacteria

Persistent pelvic pain can reflect chronic pelvic pain syndrome, pelvic floor problems or another urological diagnosis. Assess sexual symptoms, bowel symptoms and the impact on daily function; absence of bacterial evidence changes the role of antibiotics.

05InvestigationsWhat to request, why it matters and how to interpret it.

Investigation order

Read from the initial assessment onwards. Tests may run in parallel in urgent care; first-line, preferred, confirmatory, definitive and gold-standard labels appear only when the chapter explicitly states them.

01
Midstream urine bacterial cultureFirst step
Why
Identify the organism before treating a suspected acute episode.
Interpretation and limitations
Use susceptibility to refine treatment, remembering that a bladder-active result does not prove adequate prostate penetration. If the patient is severely ill, obtain blood cultures and sepsis blood tests without delaying urgent therapy.
02
Selected specialist localisation cultures
Why
Distinguish a chronic bacterial reservoir from another explanation.
Interpretation and limitations
A two-glass or four-glass localisation assessment can support chronic bacterial prostatitis in a stable patient after an acute phase has passed. Prostate massage is contraindicated during acute bacterial illness because it can provoke bacteraemia.
03
Abscess imaging when indicated
Why
Look for a collection when the course is unexpectedly severe or persistent.
Interpretation and limitations
Persistent fever, deterioration or an inadequate response should prompt specialist assessment for imaging, which may include transrectal ultrasound, CT or MRI depending on the question. No single small-study size threshold determines drainage for every abscess.
04
Targeted alternative diagnosis assessment
Why
Investigate urethritis or obstruction when the clinical history supports it.
Interpretation and limitations
Obtain first void STI NAAT when indicated and assess residual urine or flow through the appropriate service when emptying is impaired. PSA is unhelpful for diagnosing prostatitis and may be raised by inflammation.

06Differential diagnosisRealistic alternatives and the features that help distinguish them.

Chronic pelvic pain syndrome

Pelvic pain and urinary or sexual symptoms may persist without a demonstrable bacterial cause. This syndrome requires a broader assessment and cannot be diagnosed or excluded by symptom severity alone.

Urethritis

Urethral inflammation can produce dysuria and discomfort, particularly with discharge or relevant sexual exposure. Targeted infection testing helps separate this from a prostate bacterial reservoir.

Bladder outlet obstruction

Poor stream, hesitancy and incomplete emptying may arise from outlet obstruction independently of infection. Obstruction can also coexist with prostatitis and contribute to recurrent symptomatic episodes.

07ManagementImmediate care, first-line treatment, alternatives and escalation.

01Worked caseTreat a demonstrated chronic reservoirFirst stepA forty five year old has four months of recurrent dysuria and perineal discomfort.

1Three cultures have grown a similar Escherichia coli susceptibility pattern after temporary improvement with short bladder courses. He is now afebrile, voiding freely and clinically stable; urology arranges localisation testing after confirming there is no acute febrile episode.
2AlternativeThe assessment supports chronic bacterial prostatitis. The organism is trimethoprim-resistant, and microbiology identifies no appropriate safer oral alternative; renal function is normal, and there is no tizanidine, steroid use, previous quinolone reaction or relevant tendon disease. After discussing risks, he begins ciprofloxacin 500 mg orally twice daily for six weeks.
3At two weeks his pain and dysuria are improving, he remains afebrile and reports no tendon, sensory or mood symptoms. The team confirms adherence and checks that he separates the tablets from iron supplements and antacids; the planned chronic course continues rather than stopping at the acute fourteen day checkpoint.
4At six weeks urinary and perineal symptoms have resolved, with no recurrent infection over the following two months. Further culture is reserved for recurrent symptoms rather than a mandatory test of cure in an asymptomatic man; recurrence would reopen the source and diagnosis assessment.

02Acute treatmentReview the initial fourteen daysA man has acute bacterial prostatitis and can retain oral medicines without severe illness.

1Send urine for culture and start an appropriate tissue-active oral regimen after reviewing local advice, prior susceptibility and drug risks. A fluoroquinolone is restricted to situations in which other recommended antibiotics are inappropriate.
2Arrange earlier review for any worsening and hospital assessment if symptoms have not started improving within forty eight hours. At fourteen days assess symptoms, examination and available urine or blood results before stopping or prescribing a further fourteen days.
3Do not automatically apply this fourteen day review-and-extension framework to a confirmed chronic bacterial reservoir. Conversely, do not give a chronic six week course to every acute presentation without clinical review.

03Severe presentationControl sepsis retention or abscessFever with haemodynamic change, urinary retention or persistent focal infection requires hospital care.

1Obtain cultures, establish intravenous access and initiate a suitable systemic antibiotic promptly. Use the sepsis pathway when indicated, involving urology early if drainage or abscess source control may be necessary.
2A urologist selects a safe route for bladder drainage if retention is present. Urethral and suprapubic routes have different practical considerations; avoid claiming that one route is mandatory for every infected prostate.
3Review intravenous therapy at forty eight hours and step down when improvement, oral tolerance and susceptibility allow. A persistent collection or clinical decline requires a source decision, rather than merely extending the same antibiotic indefinitely.

Key medicines and prescribing safety3 treatments · regimens, roles and cautions

A prostate-active option only when other commonly recommended antibiotics are inappropriate because of resistance, contraindication, intolerance or failure.

Ciprofloxacin 500 mg film coated tablets

For acute prostatitis, NICE specifies 500 mg orally twice daily for fourteen days, then review whether to stop or continue for another fourteen days. The selected chronic bacterial regimen is 500 mg orally twice daily for four to six weeks; the worked case uses six weeks after specialist review.

Reserve treatment for documented unsuitability of other commonly recommended antibiotics. The selected SmPC renal table uses creatinine clearance: above 30 to 60 ml/min/1.73 m², give 250–500 mg every twelve hours; at 30 or below, use its explicit ≤30 branch of 250–500 mg every twenty four hours. Haemodialysis doses are given after dialysis; peritoneal dialysis also uses the daily interval. Confirm the current renal estimate and infection-specific dose. Do not use with quinolone or formulation hypersensitivity or tizanidine. Avoid prior serious quinolone reactions and concurrent corticosteroids; use particular caution with older age, renal impairment or transplantation. Discuss tendon rupture, neuropathy, mood or suicidal symptoms, dysglycaemia, QT and aortic risks, and stop promptly for serious reactions. Take one to two hours before or at least four hours after iron, calcium supplements or antacids.

A NICE acute alternative when a fluoroquinolone is inappropriate and susceptibility and the clinical situation support trimethoprim.

Trimethoprim 50 mg per 5 ml suspension

For acute prostatitis when selected with specialist advice, give 200 mg as 20 ml orally twice daily for fourteen days, then review whether another fourteen days is needed.

Use the named liquid concentration when calculating volumes. Its renal table keeps 200 mg twice daily for the first three days at eGFR 15–30 ml/min, then reduces to 100 mg as 10 ml twice daily; at eGFR below 15 the half-dose applies from the start. In dialysis, involve renal and infectious-disease specialists before prescribing. Hypersensitivity, severe hepatic insufficiency, megaloblastic anaemia and other blood dyscrasias exclude this product. A suspected severe cutaneous reaction requires immediate withdrawal and assessment; previous trimethoprim-induced SJS, TEN or DRESS rules out rechallenge. Follow potassium and renal function, particularly with ACE inhibitors, angiotensin receptor blockers or potassium-sparing drugs; avoid hazardous methotrexate use. Prolonged prostatitis treatment also requires haematological monitoring and review of folate risk.

A NICE intravenous option for acute prostatitis when severe illness or inability to take oral therapy makes admission appropriate.

Ceftriaxone 2 g intravenous preparation

An admitted adult may receive 2 g intravenously once daily, administered as an infusion lasting at least thirty minutes and reviewed within forty eight hours.

Use culture and local resistance information to confirm ongoing activity; it is not universal coverage for resistant instrumentation-associated infection. Ceftriaxone or any cephalosporin hypersensitivity is a contraindication; a severe reaction to another beta lactam also excludes treatment. Review calcium-containing intravenous fluid incompatibility, liver and renal function, diarrhoea and neurological adverse effects. Never inject a lidocaine-reconstituted solution intravenously.

08ComplicationsImportant consequences, why they occur and why they matter clinically.

Prostate abscess

A focal collection can sustain fever or pain despite an appropriate antibiotic. Imaging and specialist source assessment become necessary when the clinical response is inadequate or the patient deteriorates.

Acute retention

Prostate swelling can obstruct urine passage and produce painful bladder distension. Safe drainage requires prompt assessment and a route chosen for the patient and the available expertise.

Sepsis and recurrence

Acute infection can produce systemic organ dysfunction, while inadequately resolved bacterial infection can recur. Each outcome requires reassessment of the clinical syndrome rather than an automatic longer prescription.

09Monitoring and follow-upTreatment response, safety checks and longer-term review.

Review an acute outpatient promptly for deterioration or lack of initial improvement within forty eight hours, with hospital assessment for the recognised admission triggers.
At the acute fourteen day review, record the reason for stopping or extending rather than issuing a repeat prescription automatically; include symptoms and relevant microbiological or examination findings.
During a longer chronic course, ask specifically about medication adherence, interacting supplements, tendon symptoms, altered sensation and changes in mood, as these may not be volunteered.
When symptoms have resolved, routine post-treatment culture is not mandatory. Persistent or recurrent symptoms require reassessment of bacterial evidence, obstruction, an abscess and alternative causes of pelvic pain.

10Special situationsVariants, exceptions and circumstances that change the usual approach.

Same organism is a clue

Repeated isolates with similar identification and susceptibility suggest persistence but do not genetically prove the same strain. The inference becomes stronger when the clinical timing and localisation findings support a prostate reservoir.

Avoid acute massage

Gentle examination and vigorous massage have different purposes and risks. A diagnostic manoeuvre used in selected chronic assessment should not be transferred into an acutely infected, tender prostate.

PSA cannot settle this

Prostate inflammation can increase PSA, so measuring it during suspected prostatitis neither identifies the organism nor reliably distinguishes cancer. Revisit any separate cancer concern after the acute inflammatory context is addressed.

Nonbacterial pain deserves care

A diagnosis of chronic pelvic pain should lead to assessment and appropriate multidisciplinary symptom management. It should not be dismissed, but evidence of pain alone does not justify repeated fluoroquinolone courses.

11Common pitfallsFrequent interpretation and management errors.

01
Using repeated nitrofurantoin courses for perineal pain and recurrent infection can improve bladder symptoms while leaving a bacterial prostate source insufficiently treated.
02
Treating every chronic pelvic pain presentation with prolonged antibiotics ignores the difference between a bacterial reservoir and a nonbacterial pain syndrome.
03
Continuing ciprofloxacin through new tendon or neurological symptoms risks worsening a potentially prolonged adverse reaction.
04
Waiting for an outpatient fourteen day appointment when fever persists or retention develops overlooks an earlier hospital assessment trigger.

Find your next topic